beizray

Generic: docetaxel

Labeler: zydus pharmaceuticals usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name beizray
Generic Name docetaxel
Labeler zydus pharmaceuticals usa inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

docetaxel anhydrous 20 mg/mL

Manufacturer
Zydus Pharmaceuticals USA Inc.

Identifiers & Regulatory

Product NDC 70710-2152
Product ID 70710-2152_4efe8f3a-a176-4b69-90c8-5ba5891dccfd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA218711
Listing Expiration 2026-12-31
Marketing Start 2025-08-28

Pharmacologic Class

Established (EPC)
microtubule inhibitor [epc]
Physiologic Effect
microtubule inhibition [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707102152
Hyphenated Format 70710-2152

Supplemental Identifiers

RxCUI
1860480 1860485 2054168 2054170 2697044 2723663 2723664 2723665 2723666 2728902
UNII
699121PHCA
NUI
N0000175085 N0000175592

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name beizray (source: ndc)
Generic Name docetaxel (source: ndc)
Application Number NDA218711 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 1 VIAL, GLASS in 1 CARTON (70710-2152-1) / 4 mL in 1 VIAL, GLASS
source: ndc

Packages (1)

Ingredients (1)

docetaxel anhydrous (20 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "4efe8f3a-a176-4b69-90c8-5ba5891dccfd", "openfda": {"nui": ["N0000175085", "N0000175592"], "unii": ["699121PHCA"], "rxcui": ["1860480", "1860485", "2054168", "2054170", "2697044", "2723663", "2723664", "2723665", "2723666", "2728902"], "spl_set_id": ["8fb7d980-d6c7-468b-a9f0-adff16101a4b"], "pharm_class_pe": ["Microtubule Inhibition [PE]"], "pharm_class_epc": ["Microtubule Inhibitor [EPC]"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "1 VIAL, GLASS in 1 CARTON (70710-2152-1)  / 4 mL in 1 VIAL, GLASS", "package_ndc": "70710-2152-1", "marketing_start_date": "20250828"}], "brand_name": "BEIZRAY", "product_id": "70710-2152_4efe8f3a-a176-4b69-90c8-5ba5891dccfd", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Microtubule Inhibition [PE]", "Microtubule Inhibitor [EPC]"], "product_ndc": "70710-2152", "generic_name": "Docetaxel", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BEIZRAY", "active_ingredients": [{"name": "DOCETAXEL ANHYDROUS", "strength": "20 mg/mL"}], "application_number": "NDA218711", "marketing_category": "NDA", "marketing_start_date": "20250828", "listing_expiration_date": "20261231"}